Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
Rank in Stocks #29898
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
Share Price
$1.10
Last synced: 2023-06-07
Market Cap
$19.12M
Change (1 day)
-0.90%
Change (1 year)
0.00%
Country
US
Trade Satsuma Pharmaceuticals, Inc. (STSA)

Category

Stock price history for Satsuma Pharmaceuticals, Inc. (STSA)
Highest end of day price: $1.08 on 2023-06-01

Lowest end of day price: $15.51 on 2019-09-01
Stock price history of Satsuma Pharmaceuticals, Inc. from 2019 to 2026
Annual Stock Price Performance
Year Performance
2023 24.48%
2022 -81.02%
2021 -5.23%
2020 -69.52%
2019 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$737.68 6.34%
CH
$1.07K -5.58%
KR